Decreased Leukotriene Production [PE] - N0000008683

Pharmacologic Code	N0000008683
Pharmacologic Name	Decreased Leukotriene Production
Pharmacologic Uses	5-lipoxygenase inhibitor
Pharmacologic Concept	Physiologic Effects - [PE]
Pharmacologic Concept Description	This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

The table contains 5 products whose active ingredient are classified under the same pharmacologic class Decreased Leukotriene Production [PE].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	10122-901	Zyflo	Non-Proprietary Name: Zileuton	Tablet	Oral	Chiesi Usa, Inc.	ACTIVE
	31722-044	Zileuton	Non-Proprietary Name: Zileuton	Tablet, Film Coated, Extended Release	Oral	Camber Pharmaceuticals, Inc.	ACTIVE
	51407-741	Zileuton	Non-Proprietary Name: Zileuton	Tablet, Multilayer, Extended Release	Oral	Golden State Medical Supply, Inc.	ACTIVE
	64380-189	Zileuton	Non-Proprietary Name: Zileuton	Tablet, Multilayer, Extended Release	Oral	Strides Pharma Science Limited	ACTIVE
	64980-206	Zileuton	Non-Proprietary Name: Zileuton	Tablet, Extended Release	Oral	Rising Pharmaceuticals, Inc.	ACTIVE